Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 18 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  2. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  3. US 11771671

    Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction

    OVID THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  4. US 11773393

    Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  5. US 11771745

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  6. US 11771664

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  7. US 11766432

    Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same

    Serina Therapeutics, Inc. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  8. US 11767367

    Monoclonal antibody neo-201 for the treatment of human carcinomas

    PRECISION BIOLOGICS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  9. US 11766487

    Treatments for retinal disease

    4D MOLECULAR THERAPEUTICS INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  10. US 11767526

    Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  11. US 11766403

    Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  12. US 11759459

    Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  13. US 11759506

    AADC polynucleotides for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  14. US 11761006

    Use of MIR101 or MIR128 in the treatment of seizure disorders

    OVID THERAPEUTICS INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  15. US 11760987

    Compositions and methods for the treatment or prevention of heart failure

    The Regents of the University of California · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  16. US 11760803

    Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments

    Takeda Pharmaceutical Company Limited · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  17. US 11752217

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  18. US 11753447

    Cyclic peptides, methods of synthesis, and methods of treatment

    The Regents of the University of California · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  19. US 11753655

    Compositions and methods for treatment of neurological disorders

    The Board of Regents of the University of Texas System · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  20. US 11753381

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  21. US 11744837

    Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  22. US 11744873

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  23. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    The Board of Regents of the University of Texas System · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  24. US 11744812

    Methods of treatment

    First Wave Bio, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.